Results 211 to 220 of about 1,510,953 (378)
Open Peri-Implant Distal Radius Fracture Following Previous Treatment With a Dorsal Nail-Plate Device: A Case Report. [PDF]
Bangura A +4 more
europepmc +1 more source
A Bony Mallet Thumb with Interposition of the Nail Plate. [PDF]
Afshar A, Tabrizi A, Taleb H.
europepmc +1 more source
Fibroblast activation protein alpha‐positive (FAPα+) macrophages, a distinct subset of multiple myeloma (MM)‐associated macrophages, drive immune evasion in MM through multi‐faceted mechanisms. FAPα physically interacts with vimentin (VIM) and triggers its phosphorylation at the S72 residue, which in turn induces PD‐L1 transcription. Additionally, FAPα
Huiyao Gu +15 more
wiley +1 more source
At-home technique for debridement of nail plate thickening. [PDF]
Axler E, Neubauer Z, Lipner SR.
europepmc +1 more source
Antibody drug conjugates deliver their cytotoxic anti‐tubulin or topoisomerase I inhibitor payloads to tumors through cancer cell receptor targeting. The released drug payloads induce cellular changes that interact with radiotherapy resulting in radiosensitization that improves cancer cell kill and stimulates anti‐tumor immune responses.
Jacqueline Lesperance +17 more
wiley +1 more source
A novel nail-plate construct for the treatment of AO/OTA 31-A3.3 intertrochanteric fractures: a finite element analysis. [PDF]
Fan J +5 more
europepmc +1 more source
Diffusion of uncharged solutes through human nail plate
S. Baswan, S. K. Li, G. Kasting
semanticscholar +1 more source
Bufalin Inhibits the PI3K/AKT Pathway by Targeting GTF3C4 to Impede Breast Cancer Progression
Mechanisms of Bufalin‐Mediated Intervention in Breast Cancer. ABSTRACT Breast cancer incidence is rising globally, presenting challenges such as treatment side effects and drug resistance. Bufalin is a bufadienolides compound with potential anti‐cancer effects. This study shows that bufalin inhibits malignant proliferation of MDA‐MB‐231 and MCF‐7 cells
Siyu Guo +15 more
wiley +1 more source
Surgical avulsion of the nail plate as therapy for resistant onychomycosis: case series and literature review. [PDF]
Antônio Jabur da Cunha J +3 more
europepmc +1 more source

